Multiple sclerosis: Hematopoietic stem cell transplantation: hope and hype
- PMID: 19498429
- DOI: 10.1038/nrneurol.2009.63
Multiple sclerosis: Hematopoietic stem cell transplantation: hope and hype
Abstract
A trial of autologous hematopoietic stem cell transplantation to treat multiple sclerosis has yielded promising results, generating considerable interest within both the clinical literature and the mainstream press.the findings should, however, be interpreted with some caution, and larger, randomized trials will be required to establish the true efficacy of the approach.
Comment on
-
Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study.Lancet Neurol. 2009 Mar;8(3):244-53. doi: 10.1016/S1474-4422(09)70017-1. Epub 2009 Jan 29. Lancet Neurol. 2009. PMID: 19186105 Clinical Trial.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
